As Epstein controversy swirls, President Trump signs an executive order aiming to give cities and states more authority to ...

Commissioner Marty Makary said in an interview with Politico’s Dasha Burns that the FDA will “look at the data” surrounding ...

The agency told Bayer it needs additional time to review the non-hormonal drug, called elinzanetant. Regulators in Canada and ...

The U.S. Food and Drug Administration has extended its review of Bayer's experimental menopause relief drug, the German company said on Friday.

Mike Pence's think tank is asking the Food and Drug Administration to turn over documents related to the dangers of the ...

Food and Drug Administration Commissioner Marty Makary said in a recent interview he has no plans to change policies ...

Food and Drug Administration Commissioner Marty Makary said he has “no preconceived plans” to change the policies on mifepristone, an abortion pill that ends pregnancy before 10 weeks, in an interview ...

Missouri Attorney General Andrew Bailey, in a lawsuit, says Planned Parenthood is violating Missouri’s consumer protection law by falsely advertising medication abortions as safe.

Last week, an FDA advisory committee against the risk-benefit profile of Blenrep in combination with other therapies. Regulators and reviewers were concerned about the ocular side effects and dosing ...

China has defied regulations on such products, which vape stores across the U.S. have commonly sold despite FDA restrictions, Commissioner Marty Makary said.

The FDA commissioner said access to mifepristone will stay the same, despite ongoing reviews of safety data and pressure from ...

The U.S. Food and Drug Administration has extended its review of GSK's blood cancer drug, Blenrep, as a combination treatment, the company said on Wednesday.